Please login to the form below

Not currently logged in

Aqilion AB

This page shows the latest Aqilion AB news and features for those working in and with pharma, biotech and healthcare.

Merck KGaA and Aqilion AB partner in potential €960m deal

Merck KGaA and Aqilion AB partner in potential €960m deal

Merck KGaA and Aqilion AB have entered into an exclusive licence and strategic research partnership to advance small molecule inhibitors of the TAK1 protein, thought to play a central role in ... Aqilion will be responsible for the design and synthesis

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Subscribe to our email news alerts


Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Rare diseases: not so rare after all
The brave new world addressing rare diseases – a way ahead to better and more inclusive treatment...
Webinar: Evolving Patient Journeys - How to generate deeper insights in a changing healthcare landscape
Register now for part one in a series, Evolving Patient Journeys, in which our experts look at the main ways in which the patient journey has evolved in recent years....
It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...